- 3
- 0
- 约1.64万字
- 约 14页
- 2017-05-04 发布于浙江
- 举报
Proteasome inhibitor-based pharmacological and clinical application of
PAGE \* MERGEFORMAT 14
Proteasome inhibitor-based pharmacological and clinical application of
[Keywords:] proteasome inhibitor; cancer; treatment
[Abstract] proteasome inhibitors are a class through the ubiquitination pathway blocked by a new class of anticancer drugs, for cancer treatment has good application prospects. Proteasome is widely distributed in eukaryotic cytoplasm and nucleus, with a variety of functions protease complex, while the ubiquitin - proteasome system is the creatures selective degradation of proteins is one important way, these proteins, including transcription
您可能关注的文档
- Progress in neonatal hyperglycemia.doc
- Progress in neural stem cell research.doc
- Progress in nasal drug delivery research.doc
- Progress in non-small cell lung cancer chemotherapy.doc
- Progress in nursing administrators EQ.doc
- Progress in Modern Physical Theory of Traditional Chinese Medicine.doc
- Progress in oral gastric lavage tube Poisoning.doc
- Progress in nucleic acid immunization of malaria research.doc
- Progress in nodular goiter.doc
- Progress in pancreatic regeneration factor_0.doc
原创力文档

文档评论(0)